Description | The HER2/LUCPorter reporter cell line is designed to monitor the induction of HER2 and can be used for screening of agonists, antagonists or signaling inhibitors of HER2 induction as well as for studying the HER2 induction-related signaling pathways.
Contents : 3 ~ 4 x 10^6 cells Biosafety Level : 2 |
Immunogen | The HER2/LUCPorter reporter cell line is a stably transfected HEK 293 cell line which expresses an optimized Renilla luciferase reporter gene (RenSP) under the transcriptional control of the HER2 promoter. |
Target Species | Human |
Selection Agent | Puromycin |
Growth Properties | Adherent Morphology : Epithelial |
RCL Type | Luciferase - (LUCPorter™) |
Host | HEK293 |
Gene | ERBB2 |
Storage | Store in gas phase of liquid nitrogen. |
Reconstitution Instructions | Complete Growth Medium DMEM with 4.5 g/L glucose + 10% FBS + 4 mM L-glutamine + 1 mM sodium pyruvate + 100 units/ml penicillin + 0.1 mg/ml streptomycin + 3 ug/ml puromycin. |
Research Areas for ErbB2/Her2 Reporter Cell Line (NBP2-30092)Find related products by research area.
|
Unlocking the Potential of Biosimilars in Immuno-Oncology By Jennifer Jones, M.S.Biosimilar Antibodies: Imitation Meets InnovationIn the ever-evolving medical landscape, a new class of pharmaceuticals is emerging as a game-changer, poised to transform the way we approach... Read full blog post. |
NPC1: A Potential Target For Triple-Negative Breast Cancer By Natalia Gurule, PhD Breast Cancer is a Heterogeneous DiseaseBreast cancer is the most frequently identified malignancy in women, accounting for 30% of diagnosed cases of cancer in women in the US annuall... Read full blog post. |
Hypoxia-Dependent CAR Stabilizing Construct in T cells Improves Solid Tumor Targeting and Efficacy By Victoria Osinski, PhDDespite advances in the development of cancer immunotherapies, those specifically targeting tumors still remains limited. Currently, there is great interest in utilizing chimeric antigen rece... Read full blog post. |
Harnessing Natural Killer Cell Activity for Anti-Tumor Immunotherapy By Victoria Osinski, PhDWhat’s “Natural” About Natural Killer (NK) Cells?For immunologists, the term cytotoxicity often conjures up images of an army of antigen specific CD8+ T cells deploying to ... Read full blog post. |
Gene Symbol | ERBB2 |